Melanoma News and Research

Latest Melanoma News and Research

NYU Langone cancer expert honored with 2016 "Giants of Cancer Care" Award

Jeffrey S. Weber, MD, PhD, deputy director of NYU Langone's Perlmutter Cancer Center, has received a 2016 "Giants of Cancer Care" Award.

14 Nov 2016

Virginia Tech and CytImmune Sciences develop more effective and less toxic cancer treatment

Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor.

14 Nov 2016

TSRI study suggests new approach to limit tumor growth by targeting immune system cells

A new study led by scientists at The Scripps Research Institute suggests there may be a way to limit tumor growth by targeting immune system cells called macrophages.

11 Nov 2016

Moffitt scientists show how mathematical modeling can predict patient responses to cancer drugs

Scientists have significantly improved their understanding of cancer and have developed numerous therapies that have helped to reduce patient mortality; however, the majority of drugs that make it to the clinical trial phase of development fail, despite promising data in laboratory studies.

11 Nov 2016

Scientists identify genetic mutations in highly aggressive rhabdoid meningiomas

Meningiomas are the most common primary brain tumors, but the term encompasses over a dozen subtypes that range from benign to highly aggressive.

10 Nov 2016

Study shows many indoor tanning facilities comply with Texas under-18 ban

When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81 percent of indoor tanning facilities complied with the Texas ban on indoor tanning for those under the age of 18 in a study conducted by The University of Texas MD Anderson Cancer Center.

10 Nov 2016

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body's immune system from attacking tumors.

9 Nov 2016

Person's risk factor status may help tailor surveillance program for melanomas, study suggests

The new study, published online today by JAMA Dermatology, identifies high risk patients who may benefit from tailored surveillance.

9 Nov 2016

Dermatologists offer tips to help men develop healthy skin care routines

When it comes to skin care, men have traditionally kept it simple. However, experts say more men are now pursuing healthier, younger-looking skin.

8 Nov 2016

Scientists identify new way to block action of genetic mutations found in most cancers

Researchers at the University of Illinois at Chicago have identified a new way to block the action of genetic mutations found in nearly 30 percent of all cancers.

7 Nov 2016

Combination of immunotherapy treatments can improve survival in patients with advanced skin cancer

McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival and lowers the risk of life-threatening events.

7 Nov 2016

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.

7 Nov 2016

Gut microbiome may help improve immunotherapy response in melanoma patients

Patients with malignant melanoma - whose disease has spread - are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool.

6 Nov 2016

Combination of immunotherapy options improves survival of patients with deadly forms of skin cancer

5 Nov 2016

Immune checkpoint cancer therapies may cause rare cardiac side effects linked to unexpected immune response

Combination therapy utilizing two approved immunotherapy drugs for cancer treatment may cause rare and sometimes fatal cardiac side effects linked to an unexpected immune response.

4 Nov 2016

Research shows way to directly target genes within specific cell type

The cornerstone of genetics is the loss-of-function experiment. In short, this means that to figure out what exactly gene X is doing in a tissue of interest—be it developing brain cells or a pancreatic tumor—you somehow cut out, switch off or otherwise destroy gene X in that tissue and then watch what happens.

1 Nov 2016

Melanoma News and Research

Latest Melanoma News and Research

NYU Langone cancer expert honored with 2016 "Giants of Cancer Care" Award

Virginia Tech and CytImmune Sciences develop more effective and less toxic cancer treatment

TSRI study suggests new approach to limit tumor growth by targeting immune system cells

Moffitt scientists show how mathematical modeling can predict patient responses to cancer drugs

Scientists identify genetic mutations in highly aggressive rhabdoid meningiomas

Study shows many indoor tanning facilities comply with Texas under-18 ban

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

Person's risk factor status may help tailor surveillance program for melanomas, study suggests

Dermatologists offer tips to help men develop healthy skin care routines

Scientists identify new way to block action of genetic mutations found in most cancers

Combination of immunotherapy treatments can improve survival in patients with advanced skin cancer

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Gut microbiome may help improve immunotherapy response in melanoma patients

Combination of immunotherapy options improves survival of patients with deadly forms of skin cancer

Immune checkpoint cancer therapies may cause rare cardiac side effects linked to unexpected immune response

Research shows way to directly target genes within specific cell type

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Myriad Genetics presents research data that validates accuracy of myPath Melanoma test

Researchers identify existing drugs that appear to prevent aggressive subtype of pediatric brain tumors

New approach could overcome large immunosuppressive tumors

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Melanoma News and Research

Latest Melanoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in